Stanford Investment Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-244
| Closed | -$30K | – | 339 |
|
|
2016
Q4 | $30K | Hold |
244
| – | – | 0.01% | 198 |
|
|
2016
Q3 | $2K | Hold |
244
| – | – | ﹤0.01% | 400 |
|
|
2016
Q2 | $28K | Buy |
244
+37
| +18% | +$4.25K | 0.01% | 207 |
|
|
2016
Q1 | $29K | Buy |
207
+33
| +19% | +$4.62K | 0.02% | 200 |
|
|
2015
Q4 | $32K | Hold |
174
| – | – | 0.02% | 174 |
|
|
2015
Q3 | $27K | Hold |
174
| – | – | 0.02% | 194 |
|
|
2015
Q2 | $31K | Hold |
174
| – | – | 0.02% | 185 |
|
|
2015
Q1 | $30K | Hold |
174
| – | – | 0.02% | 188 |
|
|
2014
Q4 | $32K | Buy |
+174
| New | +$32K | 0.03% | 183 |
|